FDA Approves First Trial Using CRISPR to Correct Sickle Cell Disease Mutation
Lorna Fernandes | April 7, 2021
The early phase, first-in-human trial aims to correct the sickle mutation in blood stem cells that causes the disease
Gene Editing
New CRISPR-Based Gene Editing Tool Makes Sequential Genome Edits
University of Illinois at Chicago | February 23, 2021
With the new gene editing technique, researchers can program sequential genome edits over time
CRISPR in Cell Therapy: Will It Be Superseded by Base Editors?
Jonathan Frampton, PhD | December 16, 2020
Base editors hold great promise for safer multiplex gene editing
Scientists Develop Promising Gene Therapy for Eye Disease
Trinity College Dublin | November 27, 2020
The new therapy targets a gene mutation that causes mitochondrial dysfunction
A Timeline of the CRISPR/Cas System
Michelle Dotzert, PhD | November 11, 2020
From discovery and development to clinical applications
ERS Genomics Announces Agreement with Applied StemCell to Commercialize CRISPR Gene Editing Services and Reagents
ERS Genomics | September 28, 2020
ERS Genomics holds an exclusive worldwide license from Dr. Charpentier to the foundational patents covering CRISPR/Cas9
Light-Activated CRISPR Triggers Precision Gene Editing and Super-Fast DNA Repair
Johns Hopkins Medicine | June 18, 2020
Results of recent experiments are likely to speed up and aid understanding of the DNA activity that typically causes aging and many cancers
Discovery and Development of the CRISPR/Cas System
Clinical Lab Manager | March 26, 2020
A timeline of the CRISPR/Cas system, from the identification of a distinct repetitive sequence to its use in gene editing and beyond
New CRISPR-Cas9 Variant May Boost Precision in Gene Editing
Karolinska Institutet | September 30, 2019
The new variant reduced unintended changes in DNA compared to its wildtype, suggesting it could play a role in gene therapies that require high precision
CRISPR-Cas3 Innovation Holds Promise for Disease Cures
Cornell University | April 12, 2019
The system can efficiently erase long stretches of DNA from a targeted site in the human genome